Ann: 4DMedical signs research agreement with West Los Angeles VA, page-36

I've mentioned the options and the cash they provide...

There are unlisted options with $1.34 exercise price expiring 31 Dec 2024, so, like I said, if it doesn't hit $1.34 they will lapse, no cash flow.

The listed expiring on 31 Dec 2025, so there's a chance they get exercised and cash flow comes, there's also a risk that it doesn't.

I'm not trying some fear mongering tactic saying "sell it all, there's another capital raise" nor perpetuate and 'illogical argument', because I'm unbelievably bullish on the stock

All I'm saying is, for the last time... there may be another capital raise before the end of the year? Not a bad thing